Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Posner

Showing results (91-100 of 94) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 94 results.
Cell Systems|July 16, 2018
Dissecting RAF Inhibitor Resistance by Structure-based Modeling Reveals Ways to Overcome Oncogenic RAS SignalingOleksii S Rukhlenko, Fahimeh Khorsand, Aleksandar Krstic, et al.
Journal of Gastrointestinal Oncology|January 5, 2018
A phase 2 trial of personalized cytotoxic therapy based on tumor immunohistochemistry in previously treated metastatic pancreatic cancer patientsRamesh K Ramanathan, Glen J Weiss, Richard G Posner, et al.
Medrxiv : the Preprint Server for Health Sciences|January 3, 2024
Evaluation of FluSight influenza forecasting in the 2021-22 and 2022-23 seasons with a new target laboratory-confirmed influenza hospitalizationsSarabeth M Mathis, Alexander E Webber, Tomás M León, et al.
Nature Communications|July 26, 2024
Title evaluation of FluSight influenza forecasting in the 2021-22 and 2022-23 seasons with a new target laboratory-confirmed influenza hospitalizationsSarabeth M Mathis, Alexander E Webber, Tomás M León, et al.
Pageof 10

Showing results (91-100 of 94) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 94 results.
Cell Systems|July 16, 2018
Dissecting RAF Inhibitor Resistance by Structure-based Modeling Reveals Ways to Overcome Oncogenic RAS SignalingOleksii S Rukhlenko, Fahimeh Khorsand, Aleksandar Krstic, et al.
Journal of Gastrointestinal Oncology|January 5, 2018
A phase 2 trial of personalized cytotoxic therapy based on tumor immunohistochemistry in previously treated metastatic pancreatic cancer patientsRamesh K Ramanathan, Glen J Weiss, Richard G Posner, et al.
Medrxiv : the Preprint Server for Health Sciences|January 3, 2024
Evaluation of FluSight influenza forecasting in the 2021-22 and 2022-23 seasons with a new target laboratory-confirmed influenza hospitalizationsSarabeth M Mathis, Alexander E Webber, Tomás M León, et al.
Nature Communications|July 26, 2024
Title evaluation of FluSight influenza forecasting in the 2021-22 and 2022-23 seasons with a new target laboratory-confirmed influenza hospitalizationsSarabeth M Mathis, Alexander E Webber, Tomás M León, et al.
Pageof 10